Literature DB >> 8718440

Efficacy of feedback from quarterly laboratory comparison in maintaining quality of a hospital capillary blood glucose monitoring program.

H E Jones1, B Cleave, B Zinman, J P Szalai, H L Nichol, B R Hoffman.   

Abstract

OBJECTIVE: A 1-year randomized prospective study was conducted to investigate the efficacy of feedback from split-sample testing as part of a capillary blood glucose quality assurance program. RESEARCH DESIGN AND METHODS: A total of 124 nurses were randomized to either group A (quarterly comparisons with feedback) or group B (no feedback). The measure of nurse accuracy against the laboratory at 0, 6, and 12 months was determined by an additional five to seven split-sample tests without giving feedback to either group. Mean accuracy was determined in terms of percent absolute deviation from the laboratory result and a clinical consensus limit of +/- 20% deviation from the laboratory.
RESULTS: By 12 months, there was a significant effect of feedback on nurse agreement with the laboratory method (P = 0.022 when agreement was scored as the mean percent absolute difference and P = 0.002 when agreement was scored in terms of the +/- 20% clinical consensus limit). Nurses in the group who had received no quarterly feedback from split-sample testing produced a 3.5% greater mean percent absolute deviation from the laboratory method and 12% fewer comparisons within the acceptable +/- 20% range.
CONCLUSIONS: Feedback received from split-sample testing has a significant effect in maintaining accuracy in capillary blood glucose monitoring.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8718440     DOI: 10.2337/diacare.19.2.168

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  1 in total

1.  What do we know about how to do audit and feedback? Pitfalls in applying evidence from a systematic review.

Authors:  R Foy; M P Eccles; G Jamtvedt; J Young; J M Grimshaw; R Baker
Journal:  BMC Health Serv Res       Date:  2005-07-13       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.